News Novartis expands virtual clinical trial project with Science... Swiss pharma builds on existing collaboration with Science 37
News Apple opening health and wellness clinics for employees Speculation that clinics could test Apple health products
News Novartis to develop digital therapies with Pear Deal covers digital therapies for MS and schizophrenia
News NHS sets out roadmap for a digital future Citizen ID service among priorities over the next two years
News Nokia exec says no future for digital health unit - report Memo adds to speculation Nokia could close digital health business
News Nokia could sell or close digital health unit Brief venture into digital health could be at an end
News Hengrui gets world-first okay for platelet drug hetrombopag Hengrui's oral TPO agonist, hetrombopag, is the first in the class to be approved for thrombocytopenia caused by chemotherapy for solid tumours.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
